Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Feb 8, 2026

Aptamer-Based Target Detection Facilitated by a 3-Stage G-Quadruplex Isothermal Exponential Amplification Reaction

Aptamer-Based Target Detection Facilitated by a 3-Stage G-Quadruplex Isothermal Exponential Amplification Reaction

Published on: October 6, 2022

Nepadutant Menarini Richerche.

¹School of Medicine and Dentistry, Queen Mary and Westfield College, London, UK. a.ahluwalia@mds.qmw.ac.uk

Current Opinion in Investigational Drugs (London, England : 2000)

|January 5, 2002

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A comparative study of the role of carbon fibre reinforced polyetheretherketone and titanium intramedullary nails in patients with metastatic bone disease.

Acta orthopaedica Belgica·2025

Same author

Corrigendum to "Natural mutations of human XDH promote the nitrite (NO<sub>2</sub><sup>-</sup>)-reductase capacity of xanthine oxidoreductase: A novel mechanism to promote redox health?" [Redox Biol. 4 (67) (2023) 102864].

Redox biology·2023

Same author

Natural mutations of human XDH promote the nitrite (NO<sub>2</sub><sup>-</sup>)-reductase capacity of xanthine oxidoreductase: A novel mechanism to promote redox health?

Redox biology·2023

Same author

Sodium nitrite poisoning: A series of 20 fatalities in which post-mortem blood nitrite and nitrate concentrations are reported.

Forensic science international·2023

Same author

Diagnosis and management of arterial injuries associated with limb fracture or dislocation.

British journal of hospital medicine (London, England : 2005)·2022

Same author

The Noncanonical Pathway for In Vivo Nitric Oxide Generation: The Nitrate-Nitrite-Nitric Oxide Pathway.

Pharmacological reviews·2020

Same journal

Reporting disease control rates or clinical benefit rates in early clinical trials of anticancer agents: useful endpoint or hype?

Current opinion in investigational drugs (London, England : 2000)·2011

Same journal

Abating progressive tissue injury and preserving function after CNS trauma: The role of inflammation modulatory therapies.

Current opinion in investigational drugs (London, England : 2000)·2010

Same journal

Teriflunomide, an inhibitor of dihydroorotate dehydrogenase for the potential oral treatment of multiple sclerosis.

Current opinion in investigational drugs (London, England : 2000)·2010

Same journal

Tralokinumab, an anti-IL-13 mAb for the potential treatment of asthma and COPD.

Current opinion in investigational drugs (London, England : 2000)·2010

Same journal

Vedolizumab, a humanized mAb against the α4β7 integrin for the potential treatment of ulcerative colitis and Crohn's disease.

Current opinion in investigational drugs (London, England : 2000)·2010

Same journal

Pitrakinra, a dual IL-4/IL-13 antagonist for the potential treatment of asthma and eczema.

Current opinion in investigational drugs (London, England : 2000)·2010

See all related articles

Menarini Richerche is developing nepadutant, a novel NK2 antagonist, for treating asthma and irritable bowel syndrome. This compound is currently undergoing phase IIa clinical trials in Belgium and Sweden.

Area of Science:

Pharmacology
Gastroenterology
Pulmonology

Background:

Asthma and irritable bowel syndrome (IBS) are common conditions with unmet therapeutic needs.
The neurokinin 2 (NK2) receptor is implicated in the pathophysiology of both asthma and IBS.

Purpose of the Study:

To evaluate the efficacy and safety of nepadutant, an NK2 antagonist, in patients with asthma and IBS.
To advance nepadutant through early-stage clinical development.

Main Methods:

Phase IIa clinical trials were conducted in Belgium and Sweden.
Nepadutant was administered to patients diagnosed with asthma or IBS.

Main Results:

Nepadutant is under investigation for its therapeutic potential.

More Related Videos

Laser-induced Forward Transfer of Ag Nanopaste

Laser-induced Forward Transfer of Ag Nanopaste

Published on: March 31, 2016

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

Related Experiment Videos

Last Updated: Feb 8, 2026

Aptamer-Based Target Detection Facilitated by a 3-Stage G-Quadruplex Isothermal Exponential Amplification Reaction

Aptamer-Based Target Detection Facilitated by a 3-Stage G-Quadruplex Isothermal Exponential Amplification Reaction

Published on: October 6, 2022

Laser-induced Forward Transfer of Ag Nanopaste

Laser-induced Forward Transfer of Ag Nanopaste

Published on: March 31, 2016

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

The compound has progressed to phase IIa clinical trials, indicating preliminary safety and efficacy assessments are underway.

Conclusions:

Nepadutant shows promise as a potential treatment for asthma and IBS.
Further clinical evaluation is warranted to confirm its therapeutic utility.